ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Evaluating Health Related Utility in Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00471874
Recruitment Status : Completed
First Posted : May 10, 2007
Last Update Posted : December 13, 2007
Sponsor:
Information provided by:
Wyeth is now a wholly owned subsidiary of Pfizer

May 8, 2007
May 10, 2007
December 13, 2007
April 2007
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00471874 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Study Evaluating Health Related Utility in Rheumatoid Arthritis
An Observational Study to Examine the Relationship Between Rheumatoid Arthritis Disease Severity and Health Related Utility
The purpose of this study is to determine in Australia what effect rheumatoid arthritis has on quality of life, and also to determine the costs that are associated with having rheumatoid arthritis.

At a routine visit to the clinic, patients will be asked to answer questions about their symptoms, have a routine examination by the doctor, fill out a questionnaire that will ask questions about them, about their arthritis, about how it affects their well being and quality of life, and about treatment and costs. The questionnaire will take them about 30 minutes to complete. A blood test may also be required.

This ends the patient's involvement with the study.

Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Not Provided
Not Provided
Rheumatoid Arthritis
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
250
Same as current
December 2007
Not Provided

Inclusion Criteria:

  • Male or female patient with clinically defined rheumatoid arthritis diagnosed for at least 3 months
  • Age 18 years or older
  • Ability to complete the study documents in English

Exclusion Criteria:

· Current participation in a blinded trial of an investigational treatment

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Australia
 
 
NCT00471874
0881X1-4427
No
Not Provided
Not Provided
Not Provided
Wyeth is now a wholly owned subsidiary of Pfizer
Not Provided
Study Director: Medical Monitor Wyeth is now a wholly owned subsidiary of Pfizer
Principal Investigator: Trial Manager For Australia, medinfo@wyeth.com
Wyeth is now a wholly owned subsidiary of Pfizer
December 2007